Applied NeuroSolutions and bioMerieux in Alzheimer's test deal
This article was originally published in Clinica
Executive Summary
Applied NeuroSolutions and bioMerieux have formed a deal to bring to market what is claimed could be the first definitive biologic test for diagnosing Alzheimer's disease.